DRUG · Mapped RxNorm record
Clemastine Fumarate
Normalized identity: clemastine fumarateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
NCT05359653
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAssessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Multiple Sclerosis (MS)unresolved
Multiple Sclerosis, Relapsing-Remittingunresolved
Multiple Sclerosis, Primary Progressiveunresolved
Multiple Sclerosis, Chronic Progressiveunresolved
Multiple Sclerosis Relapseunresolved
Multiple Sclerosis Brain Lesionunresolved
Multiple Sclerosis Benignunresolved
Interventions
Clemastine FumarateDRUG · verified · RxNorm: clemastine fumarate
PlaceboDRUG
Sponsors & collaborators
University of California, San Franciscolead sponsor
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05359653 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.